Non-core region modulates interleukin-11 signaling activity: Generation of agonist and antagonist variants

Saeko Yanaka, Emiko Sano, Norio Naruse, Kin Ichiro Miura, Mutsumi Futatsumori-Sugai, Jose M.M. Caaveiro, Kouhei Tsumoto

研究成果: ジャーナルへの寄稿記事

8 引用 (Scopus)

抄録

Human interleukin-11 (hIL-11) is a pleiotropic cytokine administered to patients with low platelet counts. From a structural point of view hIL-11 belongs to the long-helix cytokine superfamily, which is characterized by a conserved core motif consisting of four α-helices. We have investigated the region of hIL-11 that does not belong to the α-helical bundle motif, and that for the purpose of brevity we have termed "non-core region." The primary sequence of the interleukin was altered at various locations within the non-core region by introducing glycosylation sites. Functional consequences of these modifications were examined in cell-based as well as biophysical assays. Overall, the data indicated that the non-core region modulates the function of hIL-11 in two ways. First, the majority of muteins displayed enhanced cell-stimulatory properties (superagonist behavior) in a glycosylation-dependent manner, suggesting that the non-core region is biologically designed to limit the full potential of hIL-11. Second, specific modification of a predicted mini α-helix led to cytokine inactivation, demonstrating that this putative structural element belongs to site III engaging a second copy of cell-receptor gp130. These findings have unveiled new and unexpected elements modulating the biological activity of hIL-11, which may be exploited to develop more versatile medications based on this important cytokine.

元の言語英語
ページ(範囲)8085-8093
ページ数9
ジャーナルJournal of Biological Chemistry
286
発行部数10
DOI
出版物ステータス出版済み - 3 11 2011

Fingerprint

Interleukin-11
Cytokines
Glycosylation
Interleukins
Platelets
Bioactivity
Platelet Count
Human Activities
Assays

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

これを引用

Non-core region modulates interleukin-11 signaling activity : Generation of agonist and antagonist variants. / Yanaka, Saeko; Sano, Emiko; Naruse, Norio; Miura, Kin Ichiro; Futatsumori-Sugai, Mutsumi; Caaveiro, Jose M.M.; Tsumoto, Kouhei.

:: Journal of Biological Chemistry, 巻 286, 番号 10, 11.03.2011, p. 8085-8093.

研究成果: ジャーナルへの寄稿記事

Yanaka, Saeko ; Sano, Emiko ; Naruse, Norio ; Miura, Kin Ichiro ; Futatsumori-Sugai, Mutsumi ; Caaveiro, Jose M.M. ; Tsumoto, Kouhei. / Non-core region modulates interleukin-11 signaling activity : Generation of agonist and antagonist variants. :: Journal of Biological Chemistry. 2011 ; 巻 286, 番号 10. pp. 8085-8093.
@article{7904acbebeb54bfb9cf4de09164e183c,
title = "Non-core region modulates interleukin-11 signaling activity: Generation of agonist and antagonist variants",
abstract = "Human interleukin-11 (hIL-11) is a pleiotropic cytokine administered to patients with low platelet counts. From a structural point of view hIL-11 belongs to the long-helix cytokine superfamily, which is characterized by a conserved core motif consisting of four α-helices. We have investigated the region of hIL-11 that does not belong to the α-helical bundle motif, and that for the purpose of brevity we have termed {"}non-core region.{"} The primary sequence of the interleukin was altered at various locations within the non-core region by introducing glycosylation sites. Functional consequences of these modifications were examined in cell-based as well as biophysical assays. Overall, the data indicated that the non-core region modulates the function of hIL-11 in two ways. First, the majority of muteins displayed enhanced cell-stimulatory properties (superagonist behavior) in a glycosylation-dependent manner, suggesting that the non-core region is biologically designed to limit the full potential of hIL-11. Second, specific modification of a predicted mini α-helix led to cytokine inactivation, demonstrating that this putative structural element belongs to site III engaging a second copy of cell-receptor gp130. These findings have unveiled new and unexpected elements modulating the biological activity of hIL-11, which may be exploited to develop more versatile medications based on this important cytokine.",
author = "Saeko Yanaka and Emiko Sano and Norio Naruse and Miura, {Kin Ichiro} and Mutsumi Futatsumori-Sugai and Caaveiro, {Jose M.M.} and Kouhei Tsumoto",
year = "2011",
month = "3",
day = "11",
doi = "10.1074/jbc.M110.152561",
language = "English",
volume = "286",
pages = "8085--8093",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "10",

}

TY - JOUR

T1 - Non-core region modulates interleukin-11 signaling activity

T2 - Generation of agonist and antagonist variants

AU - Yanaka, Saeko

AU - Sano, Emiko

AU - Naruse, Norio

AU - Miura, Kin Ichiro

AU - Futatsumori-Sugai, Mutsumi

AU - Caaveiro, Jose M.M.

AU - Tsumoto, Kouhei

PY - 2011/3/11

Y1 - 2011/3/11

N2 - Human interleukin-11 (hIL-11) is a pleiotropic cytokine administered to patients with low platelet counts. From a structural point of view hIL-11 belongs to the long-helix cytokine superfamily, which is characterized by a conserved core motif consisting of four α-helices. We have investigated the region of hIL-11 that does not belong to the α-helical bundle motif, and that for the purpose of brevity we have termed "non-core region." The primary sequence of the interleukin was altered at various locations within the non-core region by introducing glycosylation sites. Functional consequences of these modifications were examined in cell-based as well as biophysical assays. Overall, the data indicated that the non-core region modulates the function of hIL-11 in two ways. First, the majority of muteins displayed enhanced cell-stimulatory properties (superagonist behavior) in a glycosylation-dependent manner, suggesting that the non-core region is biologically designed to limit the full potential of hIL-11. Second, specific modification of a predicted mini α-helix led to cytokine inactivation, demonstrating that this putative structural element belongs to site III engaging a second copy of cell-receptor gp130. These findings have unveiled new and unexpected elements modulating the biological activity of hIL-11, which may be exploited to develop more versatile medications based on this important cytokine.

AB - Human interleukin-11 (hIL-11) is a pleiotropic cytokine administered to patients with low platelet counts. From a structural point of view hIL-11 belongs to the long-helix cytokine superfamily, which is characterized by a conserved core motif consisting of four α-helices. We have investigated the region of hIL-11 that does not belong to the α-helical bundle motif, and that for the purpose of brevity we have termed "non-core region." The primary sequence of the interleukin was altered at various locations within the non-core region by introducing glycosylation sites. Functional consequences of these modifications were examined in cell-based as well as biophysical assays. Overall, the data indicated that the non-core region modulates the function of hIL-11 in two ways. First, the majority of muteins displayed enhanced cell-stimulatory properties (superagonist behavior) in a glycosylation-dependent manner, suggesting that the non-core region is biologically designed to limit the full potential of hIL-11. Second, specific modification of a predicted mini α-helix led to cytokine inactivation, demonstrating that this putative structural element belongs to site III engaging a second copy of cell-receptor gp130. These findings have unveiled new and unexpected elements modulating the biological activity of hIL-11, which may be exploited to develop more versatile medications based on this important cytokine.

UR - http://www.scopus.com/inward/record.url?scp=79953127652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953127652&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.152561

DO - 10.1074/jbc.M110.152561

M3 - Article

C2 - 21138838

AN - SCOPUS:79953127652

VL - 286

SP - 8085

EP - 8093

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 10

ER -